Celiac Disease Market Report 2026
Download Free Sample Buy Now
Celiac Disease Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Celiac Disease Market Report 2026

Global Outlook – By Treatment (Larazotide Acetate, Gluten Free Diet, Other Treatments), By Route Of Administration (Oral, Parenteral), By End Users (Hospitals, Homecare, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Celiac Disease Market Overview

• Celiac Disease market size has reached to $0.78 billion in 2025

• Expected to grow to $1.27 billion in 2030 at a compound annual growth rate (CAGR) of 10%

• Growth Driver: Advancements In Personalized Medicine Fueling The Growth Of The Market Due To Increasing Precision In Diagnosis And Treatment

• Market Trend: Development Of Targeted Immune Therapies Driving Innovation In The Market

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Celiac Disease Market?

Celiac disease is an autoimmune disorder where gluten intake causes immune damage to the small intestine, leading to malabsorption and various symptoms. It’s diagnosed through blood tests and biopsy, and the only treatment is a lifelong gluten-free diet to heal the intestine and prevent complications.

The main treatments of celiac disease include infliximab, larazotide acetate, gluten-free diets, and others. Infliximab is a monoclonal antibody that suppresses inflammation by blocking tumor necrosis factor-alpha (TNF-a). It can be administered through oral and parenteral routes and is used by several end users, including hospitals, home care, and others.

Celiac Disease Market Global Report 2026 Market Report bar graph

What Is The Celiac Disease Market Size and Share 2026?

The celiac disease market size has grown rapidly in recent years. It will grow from $0.78 billion in 2025 to $0.87 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to autoimmune disease awareness, improved diagnostics, dietary management adoption, hospital gastroenterology care, patient advocacy.

What Is The Celiac Disease Market Growth Forecast?

The celiac disease market size is expected to see strong growth in the next few years. It will grow to $1.27 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to novel drug development, gluten-free food innovation, personalized nutrition, early screening programs, microbiome research. Major trends in the forecast period include rising adoption of gluten-free diets, growth of packaged gluten-free foods, expansion of drug-based therapies, increased disease awareness and diagnosis, focus on microbiome-based treatments.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Celiac Disease Market Segmentation

1) By Treatment: Larazotide Acetate, Gluten Free Diet, Other Treatments

2) By Route Of Administration: Oral, Parenteral

3) By End Users: Hospitals, Homecare, Other End-Users

Subsegments:

1) By Larazotide Acetate: Clinical Trial Phase Products, Oral Capsule Formulation, Adult Celiac Patients, Pediatric Investigational Use, Monotherapy And Combination Therapy

2) By Gluten Free Diet: Packaged Gluten-Free Foods, Gluten-Free Bakery Products, Gluten-Free Snacks, Gluten-Free Nutritional Supplements, Gluten-Free Beverages

3) By Other Treatments: Corticosteroids, Immunosuppressive Drugs, Enzyme Therapies, Monoclonal Antibodies, Probiotics And Microbiome Modulators

What Is The Driver Of The Celiac Disease Market?

The growth of personalized medicine is expected to drive the growth of the celiac disease market going forward. Personalized medicine is an approach to healthcare that customizes medical care based on an individual’s genetic profile, environment, and lifestyle. The demand for personalized medicine is rising due to the increasing availability of genetic testing, which enables more accurate diagnoses and targeted treatments tailored to individual patient needs. The growth of personalized medicine supports celiac disease treatment by allowing precise identification of genetic markers and individual immune responses, leading to more targeted and effective management strategies for each patient. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization, the FDA authorized 16 personalized therapies in 2023 targeting rare diseases, a rise compared to the 6 approved in 2022. Therefore, the growth of personalized medicine will boost the growth of the celiac disease industry.

Key Players In The Global Celiac Disease Market

Major companies operating in the celiac disease market are Pfizer Inc., Sanofi SA, Novartis AG, Takeda Pharmaceutical Company Ltd., Chugai Pharmaceutical Co. Ltd., Dr Falk Pharma GmbH, Theriva Biologics Inc., Equillium Inc., Immunic Inc., Barinthus Biotherapeutics Plc, Allero Therapeutics, Anokion SA, Mozart Therapeutics, ImmunogenX, Topas Therapeutics GmbH, Parvus Therapeutics Inc., AMYRA Biotech AG, Provention Limited, Precigen Inc., Zedira GmbH, AnTolRx Inc., Nemysis Ltd., Entero Therapeutics Inc.

Global Celiac Disease Market Trends and Insights

Major companies operating in the celiac disease market are focusing on developing advanced solutions, such as anti-interleukin-15 (IL-15) antibodies, to reduce tissue damage by limiting overactive immune cell activity. Anti-interleukin-15 (IL-15) antibodies are specialized proteins that inhibit the function of the IL-15 cytokine, helping to control immune system activity and inflammation. For instance, in May 2025, Teva Pharmaceutical Industries, an Israel-based pharmaceutical company, announced that the U.S. Food and Drug Administration had granted Fast Track status for TEV-53408, an investigational anti-interleukin-15 (IL-15) antibody. It is an investigational monoclonal antibody developed for individuals with celiac disease who remain on a gluten-free diet. It functions by blocking interleukin-15 (IL-15), a molecule involved in triggering the immune response that leads to intestinal harm in celiac patients. The therapy is currently being tested in a Phase 2a clinical trial to evaluate its safety and how well it works.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Celiac Disease Market?

In May 2025, Targeted Genomics, a US-based company focused on celiac disease genetics and wellness, partnered with OraSure Technologies to offer DTC genetic celiac disease testing. The partnership enables Targeted Genomics to collaborate with a knowledgeable industry player to enhance their efforts. It strengthens their aim to deliver genetic risk information directly to health-conscious individuals. OraSure Technologies is a US-based provider of celiac disease diagnostics.

Regional Insights

North America was the largest region in the celiac disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Celiac Disease Market?

The celiac disease market consists of revenues earned by entities by providing services such as diagnostic testing services, histopathology services, dietary consultation, nutrition counseling, and food certification. The market value includes the value of related goods sold by the service provider or included within the service offering. The celiac disease market also includes sales of gluten-free foods, diagnostic test kits, nutritional supplements, gluten detection devices, and probiotics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Celiac Disease Market Report 2026?

The celiac disease market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the celiac disease industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Celiac Disease Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $0.87 billion
Revenue Forecast In 2035 $1.27 billion
Growth Rate CAGR of 10.3% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Treatment, Route Of Administration, End Users
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., Sanofi SA, Novartis AG, Takeda Pharmaceutical Company Ltd., Chugai Pharmaceutical Co. Ltd., Dr Falk Pharma GmbH, Theriva Biologics Inc., Equillium Inc., Immunic Inc., Barinthus Biotherapeutics Plc, Allero Therapeutics, Anokion SA, Mozart The
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Celiac Disease Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Celiac Disease Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Celiac Disease Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Celiac Disease Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Sustainability, Climate Tech & Circular Economy

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Rising Adoption Of Gluten-Free Diets

4.2.2 Growth Of Packaged Gluten-Free Foods

4.2.3 Expansion Of Drug-Based Therapies

4.2.4 Increased Disease Awareness And Diagnosis

4.2.5 Focus On Microbiome-Based Treatments

5. Celiac Disease Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Gastroenterology Clinics

5.3 Homecare Patients

5.4 Specialty Food Manufacturers

5.5 Nutritional Therapy Providers

6. Celiac Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Celiac Disease Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Celiac Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Celiac Disease Market Size, Comparisons And Growth Rate Analysis

7.3. Global Celiac Disease Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Celiac Disease Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Celiac Disease Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Celiac Disease Market Segmentation

9.1. Global Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Larazotide Acetate, Gluten Free Diet, Other Treatments

9.2. Global Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Parenteral

9.3. Global Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Homecare, Other End-Users

9.4. Global Celiac Disease Market, Sub-Segmentation Of Larazotide Acetate, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Clinical Trial Phase Products, Oral Capsule Formulation, Adult Celiac Patients, Pediatric Investigational Use, Monotherapy And Combination Therapy

9.5. Global Celiac Disease Market, Sub-Segmentation Of Gluten Free Diet, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Packaged Gluten-Free Foods, Gluten-Free Bakery Products, Gluten-Free Snacks, Gluten-Free Nutritional Supplements, Gluten-Free Beverages

9.6. Global Celiac Disease Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Corticosteroids, Immunosuppressive Drugs, Enzyme Therapies, Monoclonal Antibodies, Probiotics And Microbiome Modulators

10. Celiac Disease Market Regional And Country Analysis

10.1. Global Celiac Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Celiac Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Celiac Disease Market

11.1. Asia-Pacific Celiac Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Celiac Disease Market

12.1. China Celiac Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Celiac Disease Market

13.1. India Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Celiac Disease Market

14.1. Japan Celiac Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Celiac Disease Market

15.1. Australia Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Celiac Disease Market

16.1. Indonesia Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Celiac Disease Market

17.1. South Korea Celiac Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Celiac Disease Market

18.1. Taiwan Celiac Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Celiac Disease Market

19.1. South East Asia Celiac Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Celiac Disease Market

20.1. Western Europe Celiac Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Celiac Disease Market

21.1. UK Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Celiac Disease Market

22.1. Germany Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Celiac Disease Market

23.1. France Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Celiac Disease Market

24.1. Italy Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Celiac Disease Market

25.1. Spain Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Celiac Disease Market

26.1. Eastern Europe Celiac Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Celiac Disease Market

27.1. Russia Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Celiac Disease Market

28.1. North America Celiac Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Celiac Disease Market

29.1. USA Celiac Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Celiac Disease Market

30.1. Canada Celiac Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Celiac Disease Market

31.1. South America Celiac Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Celiac Disease Market

32.1. Brazil Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Celiac Disease Market

33.1. Middle East Celiac Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Celiac Disease Market

34.1. Africa Celiac Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Celiac Disease Market Regulatory and Investment Landscape

36. Celiac Disease Market Competitive Landscape And Company Profiles

36.1. Celiac Disease Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Celiac Disease Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Celiac Disease Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Takeda Pharmaceutical Company Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Chugai Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Celiac Disease Market Other Major And Innovative Companies

Dr Falk Pharma GmbH, Theriva Biologics Inc., Equillium Inc., Immunic Inc., Barinthus Biotherapeutics Plc, Allero Therapeutics, Anokion SA, Mozart Therapeutics, ImmunogenX, Topas Therapeutics GmbH, Parvus Therapeutics Inc., AMYRA Biotech AG, Provention Limited, Precigen Inc., Zedira GmbH

38. Global Celiac Disease Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Celiac Disease Market

40. Celiac Disease Market High Potential Countries, Segments and Strategies

40.1 Celiac Disease Market In 2030 - Countries Offering Most New Opportunities

40.2 Celiac Disease Market In 2030 - Segments Offering Most New Opportunities

40.3 Celiac Disease Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Celiac Disease Market, Overview Of Key Products - Product Examples
  • Table 2: Global Celiac Disease Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Celiac Disease Market, Supply Chain Analysis
  • Table 4: Global Celiac Disease Market, Major Raw Material Providers
  • Table 5: Global Celiac Disease Market, Major Resource Providers
  • Table 6: Global Celiac Disease Market, Major Manufacturers (Suppliers)
  • Table 7: Global Celiac Disease Market, Major Distributors And Channel Partners
  • Table 8: Global Celiac Disease Market, Key Technologies & Future Trends
  • Table 9: Global Celiac Disease Market, Major Trends
  • Table 10: Global Celiac Disease Market, Major End Users
  • Table 11: Global Celiac Disease Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Celiac Disease Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Celiac Disease Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Celiac Disease Market - TAM, US$ Billion, 2025
  • Table 15: Global Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Celiac Disease Market, Sub-Segmentation Of Larazotide Acetate, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Celiac Disease Market, Sub-Segmentation Of Gluten Free Diet, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Celiac Disease Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Celiac Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Celiac Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Celiac Disease Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Celiac Disease Market - Company Scoring Matrix
  • Table 97: Pfizer Inc. Financial Performance
  • Table 98: Sanofi SA Financial Performance
  • Table 99: Novartis AG Financial Performance
  • Table 100: Takeda Pharmaceutical Company Ltd. Financial Performance
  • Table 101: Chugai Pharmaceutical Co. Ltd. Financial Performance
  • Table 102: Global Celiac Disease Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Celiac Disease Market, Competitive Dashboard
  • Table 104: Global Celiac Disease Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Celiac Disease Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Table 106: Global, Celiac Disease Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Table 107: Global, Celiac Disease Market Size Gain ($ Billion), Segmentation By End Users, 2025 – 2030

List Of Figures

    Figure 1: Global Celiac Disease Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Celiac Disease Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Celiac Disease Market, Supply Chain Analysis
  • Figure 4: Global Celiac Disease Market, Major Raw Material Providers
  • Figure 5: Global Celiac Disease Market, Major Resource Providers
  • Figure 6: Global Celiac Disease Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Celiac Disease Market, Major Distributors And Channel Partners
  • Figure 8: Global Celiac Disease Market, Key Technologies & Future Trends
  • Figure 9: Global Celiac Disease Market, Major Trends
  • Figure 10: Global Celiac Disease Market, Major End Users
  • Figure 11: Global Celiac Disease Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Celiac Disease Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Celiac Disease Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Celiac Disease Market - TAM, US$ Billion, 2025
  • Figure 15: Global Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Celiac Disease Market, Sub-Segmentation Of Larazotide Acetate, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Celiac Disease Market, Sub-Segmentation Of Gluten Free Diet, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Celiac Disease Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Celiac Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Celiac Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Celiac Disease Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Celiac Disease Market - Company Scoring Matrix
  • Figure 97: Pfizer Inc. Financial Performance
  • Figure 98: Sanofi SA Financial Performance
  • Figure 99: Novartis AG Financial Performance
  • Figure 100: Takeda Pharmaceutical Company Ltd. Financial Performance
  • Figure 101: Chugai Pharmaceutical Co. Ltd. Financial Performance
  • Figure 102: Global Celiac Disease Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Celiac Disease Market, Competitive Dashboard
  • Figure 104: Global Celiac Disease Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Celiac Disease Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Figure 106: Global, Celiac Disease Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Figure 107: Global, Celiac Disease Market Size Gain ($ Billion), Segmentation By End Users, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Rare Diseases Treatment Market Report 2026 - Global Outlook – By Drug Type (Originator Drugs (Patented Molecules), Generic Drugs), By Drug Class (Biologics, Organic Compounds), By Mode Of Administration (Injectable, Oral...

Rare Disease Diagnostics Market Report 2026 - Global Outlook – By Test Type (Genetic Test, General Lab Test, Imaging Test), By Technology (Capillary Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Microarray...

Rare Inflammatory Disease Treatment Market Report 2026 - Global Outlook – By Drug Class (Biologics, Organic Compounds), By Mode Of Administration (Injectables, Oral, Other Administration Modes), By Indication (Ulcerative...

Enteric Disease Testing Market Report 2026 - Global Outlook – By Disease Type (Bacterial Enteric Disease, Parasitic Enteric Disease, Viral Enteric Disease, Other Disease Types), By Technology (Traditional, Rapid, Conveni...

Ulcerative Colitis Market Report 2026 - Global Outlook – By Drug Type (Anti-Inflammatory Drugs, Anti-TNF Biologics, Immunosuppressant, Calcineurin Inhibitors, Other Drug Types), By Disease Type (Ulcerative Proctitis, Pro...

Autoimmune Disease Diagnosis Market Report 2026 - Global Outlook – By Product (Consumables And Assay Kits, Instruments), By Test Type (Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests), By E...

Inflammatory Bowel Disease Treatment Market Report 2026 - Global Outlook – By Drug Class (Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes), By Type (Cro...

Gastrointestinal Pathogen Testing Market Report 2026 - Global Outlook – By Pathogen Type (Bacteria, Viruses, Parasites), By Test Type (Molecular Tests, Culture, Biochemical Tests, Other Test Types), By Panel Type (Syndro...

Frequently Asked Questions

The Celiac Disease market was valued at $0.78 billion in 2025, increased to $0.87 billion in 2026, and is projected to reach $1.27 billion by 2030.

The global Celiac Disease market is expected to grow at a CAGR of 10.0% from 2026 to 2035 to reach $1.27 billion by 2035.

Some Key Players in the Celiac Disease market Include, Pfizer Inc., Sanofi SA, Novartis AG, Takeda Pharmaceutical Company Ltd., Chugai Pharmaceutical Co. Ltd., Dr Falk Pharma GmbH, Theriva Biologics Inc., Equillium Inc., Immunic Inc., Barinthus Biotherapeutics Plc, Allero Therapeutics, Anokion SA, Mozart Therapeutics, ImmunogenX, Topas Therapeutics GmbH, Parvus Therapeutics Inc., AMYRA Biotech AG, Provention Limited, Precigen Inc., Zedira GmbH, AnTolRx Inc., Nemysis Ltd., Entero Therapeutics Inc. .

Major trend in this market includes: Development Of Targeted Immune Therapies Driving Innovation In The Market. For further insights on this market. request a sample here

North America was the largest region in the celiac disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us